[1] Bayanov, B., Belov, V., Kindyuk, V., Oparin, E. and Taskaev, S. (2004) Lithium Neutron Producting Target for BINP Accelerator-Based Neutron Source. Applied Radiation and Isotopes, 61, 817-821.
http://dx.doi.org/10.1016/j.apradiso.2004.05.032
[2] Willis, C., Lenz, J. and Swenson, D. (2008) High-Power Lithium Target for Accelerator-Based BNCT. Proceedings of LINAC08, Victoria, MOP063, 223-225.
[3] Halfon, S., Paul, M., Arenshtam, A., Berkovits, D., Bisyakoev, M., Eliyahu, I., Feinberg, G., Hazenshprung, N., Kijel, D., Nagler, A. and Silverman, I. (2011) High Power Accelerator-Based Boron Neutron Capture with a Liquid Lithium Target and New Applications to Treatment of Infections Diseases. Applied Radiation and Isotopes, 69, 1654-1656.
http://dx.doi.org/10.1016/j.apradiso.2011.03.016
[4] Ishiyama, S., Baba, Y., Fujii, R., Nakamura, M. and Imahori, Y. (2012) In-Situ Vacuum Deposition Technique of Lithium on Neutron Production Target for BNCT. Nuclear Instruments and Methods in Physics Research, B288, 18-22.
http://dx.doi.org/10.1016/j.nimb.2012.07.024
[5] Ishiyama, S., Baba, Y., Fujii, R., Nakamura, M. and Imahori, Y. (2012) Synthesis of Lithium Nitride for Neutron Producton Target of BNCT by In-Situ Lithium Deposition and Ion Implantation. Nuclear Instruments and Methods in Physics Research, B293, 42-47.
http://dx.doi.org/10.1016/j.nimb.2012.09.016
[6] Coderre, J.A., Morris, G.M., Micca, P.L., Fishe, C.D. and Ross, G.A. (1995) Comparative Assessment of Single-Dose and Fractional Boron Neutron Capture Therapy. Radiation Research, 166, 310-317.
http://dx.doi.org/10.2307/3578951
[7] Bath, R.F., Soloway, A.H., Goodman, J.H., Gahbauer, R.A., Gupta, N., Blue, T.E., Yang, W. and Tjarks, W. (2004) Boron Neutron Capture Therapy of Brain Tumors: An Merging Therapeutic Modality 2. Neyrosurgery, 44, 433-451.
[8] Coderre, J.A. and Morris, G.M. (1999) The Irradiation Biology of Boron Neutron Capture Therapy. Radiation Research, 151, 1-18.
http://dx.doi.org/10.2307/3579742
[9] Morrsi, G.M., Coderre, J.A., Hopewell, J.W., Micca, P.L. and Rezvani, M. (1994) Response of the Skin to Boron Neutron Capture Therapy with p-Boronopenylalanine or Borocaptate Sodium. Radiotherapy & Oncology, 39, 253-259.
[10] Fukuda, H., Kobayashi, T., Hiratsuka, J., et al. (1989) Estimation of Absorbed Dose in the Covering Skin of Human Melaoma Treated by Boron Capture Therapy. Pigment Cell Research, 2, 365-369.
http://dx.doi.org/10.1111/j.1600-0749.1989.tb00222.x
[11] Kiger, J.L., Kiger, W.S., Riley, K.J., Binns, P.J., Patel, H., Hopewell, J.W., Harling, O.K., Busse, P.M. and Coderre, J.A. (2008) Functional and Histological Changes in Rat Lung after Boron Neutron Capture Therapy. Radiation Research, 171, 60-69.
http://dx.doi.org/10.1667/RR1266.1
[12] Suzuki, M., Masunaga, S., Kinachi, Y., Takagai, M., Sakurai, Y., Kobayashi, T. and Ono, K. (2000) The Effects of Boron Neutron Capture Therapy on Liver Tumors and Normal Hepatocytes in Mice. Japanese Journal of Cancer Research, 91, 1058-1064.
http://dx.doi.org/10.1111/j.1349-7006.2000.tb00885.x
[13] Morris, G.M., Smith, H.P., et al. (2000) Boron Microlocalization in Oral Mucosal Tissue. British Journal of Cancer, 82, 1764-1771.
http://dx.doi.org/10.1054/bjoc.2000.1148
[14] Ishiyama, S. and Imahori, Y. (2014) Deterministic Parsing Model of the Compound Biological Effectiveness (CBE) Factor for Intracellular 10Boron Distribution in Boron Neutron Capture Therapy. International Congress on Neutron Capture Therapy (ICNCT2014), Finland, 14-19 June 2014, 162-163.
[15] Ishiyama, S. (2014) Deterministic Parsing Model of the Compound Biological Effectiveness (CBE) Factor for Intracellular 10Boron Distribution in Boron Neutron Capture Therapy. Journal of Cancer Therapy, 5, 1388-1398.
http://dx.doi.org/10.4236/jct.2014.514140
[16] Imahori, Y., Ueda, S., Ohmori, Y., et al. (1998) Fluorine-18-Labeled Fluoroboronophenylalanine PET in Patients with Glioma. Journal of Nuclear Medicine, 39, 325-333.
[17] Imahori, Y., et al. (1998) Positron Emission Tomography-Based Boron Neutron Capture Therapy Using Boronophenylalanine for High-Grade Gliomas: Part II. Clinical Cancer Research, 4, 1833-1841.